The right treatment for lymphoma depends on several factors. A hematologist (blood cancer doctor) can help you determine the best options based on:
- Age
- General health
- Type of lymphoma
- Whether the cancer has spread into your blood or other parts of your body
Lymphoma treatment: the Penn Medicine advantage
If you choose the Penn Medicine Blood Cancer Program for your lymphoma treatment, you’ll find:
- Innovative treatment options: We offer every type of treatment for lymphoma, including the newest, most advanced options. Our options include immunotherapy, CAR T cell therapy, and bloodless transplantation.
- Specialized expertise: Lymphoma treatment has changed significantly in the past few years. New treatments are now available for very specific subsets of patients. Our physicians have special training and experience exclusively in lymphoma and its subtypes. Our lymphoma team can choose the appropriate therapy based on the details of your case.
- Help for even the most complex cases: Because we offer the most advanced treatment options, we can treat the most complex cancers. Even if treatment elsewhere has not been successful, we might have a new, up-and-coming option for you.
- A history of leadership in lymphoma treatment: Penn is a longstanding international leader in the treatment of hematological malignancies. We helped develop many of the current treatments and teach others around the world about effective treatment.
Rated “exceptional” by The National Cancer Institute
Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.